Group 1 - The company forecasts a net profit of between 235 million yuan and 265 million yuan, representing an increase of 105.41 million yuan to 135.41 million yuan compared to the same period last year, with a year-on-year growth of 89.37% to 114.85% [1] - The previous year's net profit attributable to shareholders was 129.59 million yuan, with a basic earnings per share of 0.06 yuan [1] - The main reasons for the profit increase include a rise in sales and prices of key products such as Polyvinyl Alcohol (PVA), vinyl acetate, and methyl acetate [1] Group 2 - The company has seen a significant increase in export volumes, with PVA exports growing by over 40%, methyl acetate by over 30%, and VAE emulsion by over 210% [2] - The company is enhancing its R&D investment to overcome technical barriers in high-end products, transitioning from a "cost leadership" to a "technology leadership" strategy, which has improved operational performance [2] - The gross profit margins for products like PVA and polyester chips have increased, enhancing overall profitability [2]

Core Viewpoint - The collaboration between Sika and Bader Group aims to develop sustainable solutions in the water-based resin materials sector, focusing on reducing volatile organic compounds (VOCs) emissions in coatings [1] Group 1: Strategic Collaboration - Sika has signed a strategic cooperation framework agreement with Bader Group, a leading Chinese water-based emulsion company [1] - The partnership will initiate the "Zero SVOCs Coating Emulsion Solution Project," targeting the development of low SVOCs emissions coatings [1] Group 2: Innovation and Development Focus - Both companies will leverage their technological strengths to enhance the environmental performance and market competitiveness of coatings [1] - Future efforts will concentrate on high-performance eco-friendly resin development and low SVOCs release solutions [1] Group 3: Industry Impact and Commitment - The collaboration is seen as a critical step in Sika's Asia-Pacific strategy and a significant practice in addressing the industry's green transformation [1] - Bader Group plans to increase investment in environmental technology research and development to enhance product eco-friendliness [1]

星标★IPO日报 精彩文章第一时间推送 在公告中，锦盛新材表示："立案调查期间，公司将积极配合中国证监会的各项工作，严格按照相关规定及监管要求履行信息披露义务。"公司强调，目前 各项生产经营活动正常开展，该事项不会对正常经营产生重大影响。 据悉，锦盛新材成立于1998年，是一家"亚克力容器专业制造商"，主要从事化妆品塑料包装容器的研发、生产和销售，集产品设计、模具制造、注塑、烫 金、涂装、成品组装于一体。 其产品规格超过1000种，主要产品包括膏霜瓶系列产品和乳液瓶系列产品。客户包括雅诗兰黛、上海家化、华熙生物等国内外知名化妆品企业。 IPO日报发现，自2020年7月登陆创业板后，公司业绩似乎上演了"变脸"戏码。 结合财务数据来看，锦盛新材上市次年即由盈转亏，2021年归母净利润由上市当年的3448.94万元下滑至1058.70万元，2022年至2024年归母净利润分别亏 损2250.95万元、2387.49万元、2264.75万元，连续三年亏损累计超6900万元。 对于持续亏损，管理层在5月13日接受投资者调研时解释："公司经营成果、盈亏状况受多种因素影响"，承诺将"全力以赴做好经营管理工作"。 AI制图 ...

星标 ★ IPO日报 精彩文章第一时间推送 6月27日晚，浙江锦盛新材料股份有限公司（300849.SZ，下称"锦盛新材"）发布公告称，公司收到中国证监会下发的《立案告知书》， 因涉嫌信息披露违法违规，证监会决定对公司正式立案调查。 AI制图 在公告中，锦盛新材表示："立案调查期间，公司将积极配合中国证监会的各项工作，严格按照相关规定及监管要求履行信息披露义 务。"公司强调，目前各项生产经营活动正常开展，该事项不会对正常经营产生重大影响。 其产品规格超过1000种，主要产品包括膏霜瓶系列产品和乳液瓶系列产品。客户包括雅诗兰黛、上海家化、华熙生物等国内外知名化妆品 企业。 截至2025年3月末，公司实际控制人为阮荣涛、高丽君夫妇，两人直接持股23.11%，合计控制公司35.11%股权。在立案消息披露前一个 交易日，锦盛新材股价报收16.48元/股，总市值24.72亿元，计算下来，阮氏家族持股市值约8.78亿元。 IPO日报发现，自2020年7月登陆创业板后，公司业绩似乎上演了"变脸"戏码。 结合财务数据来看，锦盛新材上市次年即由盈转亏，2021年归母净利润由上市当年的3448.94万元下滑至1058.70万元， ...

6 月 27 日晚间，雅诗兰黛的包材商锦盛新材发布公告称，公司于 2025 年 6 月 27 日收到 证监会下发的《立案告知书》，因公司涉嫌信息披露违法违规，证监会决定对公司立案。 【导读】锦盛新材遭证监会立案调查 中国基金报记者 安曼 净亏损状态，最近三年亏损合计超 6900 万元。 锦盛新材表示，立案调查期间，公司将积极配合证监会的各项工作，严格按照相关规定及监 管要求履行信息披露义务。目前，公司各项生产经营活动均正常开展，上述事项不会对公司 的正常生产经营活动产生重大影响。 公开资料显示，锦盛新材主要从事化妆品塑料包装容器的研发、生产和销售，主要产品包括 膏霜瓶系列产品和乳液瓶系列产品。公司产品规格超过 1000 种，为雅诗兰黛 (Estée Lauder) 、欧诗漫、上海家化、华熙生物、福瑞达、巨子生物、广州环亚、温碧泉、卡姿 兰、林清轩等国内外知名化妆品企业提供高品质、多样化的化妆品塑料包装容器整体解决方 案。 锦盛新材于 2020 年 7 月 10 日在深交所创业板正式挂牌。不过，上市第二年，锦盛新材的 业绩就急转直下，从 2022 年开始由盈转亏，虽然 2024 年净利润同比小幅增长，但仍处于 ...

Group 1 - The founder of Cat King Sound, Zeng Dejun, responded to a controversial video regarding Lei Jun, stating he has no negative opinions towards Lei Jun or Xiaomi and hopes for no further misinterpretations [1][3] - The 2025 New Fortune Rich List revealed that Zhong Shanshan lost his position as the richest person, while Lei Jun's family saw a significant wealth increase of 96%, reaching a market value of 201 billion yuan, moving up to the 6th position [4] - Vivo's legal department announced that it has initiated an internal investigation regarding the leakage of product information by a third party, which has resulted in the involved party admitting fault and bearing compensation [13] Group 2 - Starbucks confirmed it is not considering a full sale of its Chinese business, despite previous reports suggesting otherwise [9] - Anker Innovation announced a recall of 712,900 power banks due to safety risks, which could lead to economic losses ranging from 106 million to 163 million yuan if all users opt for full refunds [32] - Neta Auto may face the risk of returning over 2 billion Thai Baht (approximately 438 million yuan) in subsidies due to not meeting production targets in Thailand [27]

罗马仕充电宝在宣布召回49万产品后，却遭遇寄送难题。 整理 ｜袁思 点击上方【36氪随声听】，一键收听大公司热门新闻。听完音频记得添加进入 【我的小程序】 中哟！ 斯坦德机器人（无锡）股份有限公司 36氪获悉，近日，斯坦德机器人（无锡）股份有限公司向港交所主板提交上市申请书，中信证券、国泰君安国际为联席保荐 人。爱企查App显示，斯坦德机器人（无锡）股份有限公司成立于2016年6月，法定代表人为王永锟，注册资本约2210.52万元 人民币，经营范围包括智能机器人的研发、人工智能应用软件开发、智能机器人销售等。融资信息显示，该公司已完成多轮融 资，投资方包括博华资本、小米集团、中信建投资本等。 天康生物 36氪获悉，天康生物公告，公司控股子公司天康制药拟公开发行股票并在北交所上市，已向北交所报送申报材料，并于6月23 日收到北交所出具的《受理通知书》。 印度空难已确认259名遇难者身份 大金重工 36氪获悉，大金重工公告，公司拟发行境外上市外资股（H股）并在香港联合交易所有限公司主板挂牌上市，以进一步夯实全 球化战略布局，提升国际市场综合竞争实力。此次发行尚需提交中国证监会、香港联交所及香港证监会备案或核准。此 ...

Core Viewpoint - Kao Corporation announced a recall of certain batches of its Curél lotion (410ml pump) due to the incorrect filling of an old formula, although these affected products were not sold in the Chinese market [1] Group 1 - Kao's Curél lotion recall is due to a mistake in filling old formula batches [1] - The company confirmed that the recalled batches were not available in the Chinese market [1]

General Provisions - The company aims to protect the legal rights of the company, shareholders, employees, and creditors, and to regulate its organization and behavior according to relevant laws and regulations [1][2] - The company is established as a joint-stock limited company in Wuxi, with a registered capital of RMB 182.30199 million [2][3] - The company was approved by the China Securities Regulatory Commission for its initial public offering of 27 million shares on June 29, 2016 [1][3] Business Objectives and Scope - The company's business objectives emphasize customer supremacy, quality, technology, and strict management [3] - The business scope includes research and development, technical consulting, manufacturing, and sales of various chemical products and plastic products [3] Shares - The company issues shares in the form of stocks, with all shares being ordinary shares totaling 182.30199 million [4][5] - The issuance of shares follows principles of openness, fairness, and justice, ensuring equal rights for all shares of the same category [4][5] - The company may increase capital through various methods, including issuing shares to unspecified objects or existing shareholders [4][5] Shareholder Rights and Responsibilities - Shareholders have rights to dividends, attend meetings, supervise the company, and transfer their shares [7][8] - Shareholders must comply with laws and the company's articles of association, and they are liable for their subscribed shares [11][12] - The company must maintain a shareholder register based on records from the securities registration and settlement institution [7][8] Shareholder Meetings - The company holds annual and temporary shareholder meetings, with specific procedures for calling and conducting these meetings [16][18] - Shareholders holding more than 10% of shares can request a temporary meeting, and the board must respond within a specified timeframe [18][19] - The company must provide legal opinions on the meeting's legality and ensure proper documentation of the meeting proceedings [21][24] Voting and Resolutions - Resolutions can be ordinary or special, with ordinary resolutions requiring a simple majority and special resolutions requiring two-thirds approval [26][27] - The company must ensure that all proposals are clearly stated and that shareholders are informed of their rights to vote and participate [21][26] - Meeting records must be maintained for ten years, documenting all proceedings and decisions made during the meetings [25][26]

精英计划-人才需求 | 万华化学 【SynBioCon】 获 悉， 近期，万华化学发布，面向全球招聘顶尖专家人才。 从招聘的方向来看，涉及十大领域：1. 包装材料 、2.PVC、3. ePTFE膜材料、4. 生物制造膜产品 、5. 高端 光学膜、6. 聚烯烃薄膜、7. 合成生物学 、8. 电解槽及电极、9. 正负极产品、10. 电池材料。 以下是生物基和合成生物学相关领域情况： 1. 包装材料： 生物降解材料成亮点 万华不仅提供传统聚烯烃薄膜方案（如LDPE, HDPE, EVOH, COCs, m-PE），更重点布局了全生物降解包装 解决方案。 其PBAT系列产品已覆盖多种应用场景： 热收缩膜 (TF2001 NL)、缓冲气泡膜 (TF2001 M04A)、缓冲气垫膜 (TF2003 M04BU)、缓冲气柱膜 (TF2001 M02A)。 4. 生物制造分离纯化膜材料： 降本增效的关键 分离纯化是生物制造（如生物基化学品、燃料、材料单体生产）中成本最高（占50%-80%）、难度最大的 环节。 高效分离膜是解决这一痛点的核心。 万华化学正积极开发微滤(MF)、纳滤(NF)、超滤(UF)、反渗透(RO)膜及中空 ...